FDA Clears Noninvasive Device for Intractable Pain
-
The US Food and Drug Administration (FDA) has cleared a noninvasive neuromodulation device (Stimpod NMS460, Xavant Technology) for the relief of chronic intractable pain, the company has announced. This ground-breaking technology has the ability to help tens if not hundreds of millions of people just in the US as a valuable treatment asset for neurologists, chiropractors, acupuncturists, physical therapists, physiatrists, and medical pain practitioners
-
@manideepa The device applies a unique, patented pulsed radiofrequency (PRF) waveform to the affected area transcutaneously. This waveform creates electromagnetic effects similar to invasive PRF treatments. Several case studies have shown instant and dramatic relief of chronic intractable pain